423 results on '"Sechi, Elia"'
Search Results
2. Neurologic manifestations of autoimmunity with immune checkpoint inhibitors
3. Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia
4. Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective
5. Autoimmune encephalitis misdiagnosis and mimics
6. Tumefactive Demyelination in MOG Ab–Associated Disease, Multiple Sclerosis, and AQP-4-IgG–Positive Neuromyelitis Optica Spectrum Disorder
7. Autoimmune Demyelinating Syndromes: Aquaporin-4-IgG-positive NMOSD and MOG - IgG Associated Disorder
8. Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody–Associated Disease
9. Neurologic Complications of Immune Checkpoint Inhibitors in Thoracic Malignancies
10. Progressive Quadriparesis and Cancer
11. Rapidly Progressive Numbness and Weakness After Soft-Tissue Abscess
12. NMOSD and MOGAD.
13. MR Imaging Features of Critical Spinal Demyelinating Lesions Associated with Progressive Motor Impairment.
14. The frequency of longitudinally extensive transverse myelitis in MS: A population-based study
15. Epidemiology of seropositive myasthenia gravis in Sardinia: A population‐based study in the district of Sassari.
16. Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis
17. Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions
18. Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade
19. Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes
20. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis
21. Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis
22. Timing and Predictors of T2-Lesion Resolution in Patients With Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
23. Non‐demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review
24. Beyond Giant Cell Arteritis and Takayasu’s Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers
25. Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.
26. Cerebral enhancement in MOG antibody-associated disease.
27. Chapter 28 - Neurologic manifestations of autoimmunity with immune checkpoint inhibitors
28. Chapter 21 - Antibodies to neural cell surface and synaptic proteins in paraneoplastic neurologic syndromes
29. Unilateral motor progression in MS: Association with a critical corticospinal tract lesion
30. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS
31. Cerebral enhancement in MOG antibody-associated disease
32. Immune Checkpoint Inhibitor Associated Central Nervous System Autoimmunity
33. Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS
34. Timing and Predictors of T2-Lesion Resolution in MOGAD (P13-5.028)
35. Epidemiology of Antibody-positive Myasthenia Gravis in Sardinia, Italy (P2-5.027)
36. Cerebral Attacks in MOG Antibody-Associated Disease: Clinical Spectrum and Fulfillment of ADEM criteria (S40.007)
37. Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology
38. Hypertrophic olivary degeneration mimics relapse in neuromyelitis optica spectrum disorder
39. Diagnosis and Management of Autoimmune Dementia
40. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
41. Author Response: Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis
42. Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review
43. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study
44. Ceftriaxone for Alexander’s Disease: A Four-Year Follow-Up
45. Spinal Central Canal Dilation in MOG Antibody-Associated Disease Versus Other CNS Demyelinating Disorders
46. Autoimmune Encephalitis Misdiagnosis: A Review of Reported Cases
47. Exposure to TNF Inhibitors is Rare at MOGAD Diagnosis
48. Development of New or Enlarging MRI Lesions Outside of Clinical Attacks in MOG-Antibody-Associated Disease
49. Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease
50. Editorial: Immune-mediated disorders of the spinal cord: Diagnosis, treatment strategies, and outcomes in the 21st century
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.